öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÁõ»ÀÈ»
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º34

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§Ôº
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ÖÐÐÔÁ£Ï¸°ûÓë°©ÔöÖ³µÄÏà¹ØÐÔ
Ñо¿ÁìÓò£º ÖÐÐÔÁ£Ï¸°ûÓë°©ÔöÖ³µÄÏà¹ØÐÔ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºlhrlhr9050@sina.com


¸öÈ˼òÊö :
Áõ»ÀÈ»£¬ÄУ¬1975Äê1ÔÂÉú£¬¸±½ÌÊÚ£¬Ò½Ñ§²©Ê¿¡£1994Äê9Ô¡ª1999Äê7Ô±ÏÒµÓÚ´óÁ¬Ò½¿Æ´óѧҽÁÆϵ£¬»ñѧʿѧλ¡£2000Äê7Ô¡ª2003Äê7Ô´óÁ¬Ò½¿Æ´óѧÑо¿ÉúÔº£¬»ñ¿ÆÑÐÐÍÆÕÍâ¿Æ˶ʿѧλ¡£2003Äê½øÈë´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚÒ»Ò½ÔºÆÕÍâ¿Æ¹¤×÷¡£2005Äê1Ô¡ª2009Äê3ÔÂÖÁÈÕ±¾¶«¾©Ò½¿Æ´óѧ¹¥¶ÁÍâ¿Æ²©Ê¿Ñ§Î»¡£2009Äê3Ô»ñҽѧ²©Ê¿Ñ§Î»¡£2009ÄêÖÁ½ñ ´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚÒ»Ò½ÔºÆÕÍâ¿Æ´ÓÊÂÁÙ´²¼°¿ÆÑй¤×÷ÔÚSCIѧÊõ¿¯ÎïÉÏ·¢±íÂÛÎÄ7ƪ£¨ÆäÖÐ3ƪΪµÚÒ»×÷Õß¼°Í¨Ñ¶×÷Õߣ¬2ƪΪµÚÒ»×÷Õߣ¬1ƪͨѶ×÷Õߣ¬1ƪµÚÈý×÷Õߣ©¡£Ö÷ÒªÊÇÓйØÖÐÐÔÁ£Ï¸°ûÓë°©ÔöÖ³Ïà¹ØÐÔ·½ÃæµÄÑо¿¡£

¿ÆÑй¤×÷ :
ÔÚÑÐÏîÄ¿£º
¿ÆÑÐÁ¢Ï ¡°ÖÐÐÔÁ£Ï¸°ûÁ×Ëá¶þõ¥Ã¸µÄ»ùÒò±í´ïºÍ»îÐÔÔÚÖ×Áö΢¹ÛÃâÒßÖеÄ×÷Óá±»ñÁÉÄþÊ¡ÈËÉçÌü¡°ÁôѧÈËÔ±¿Æ¼¼»î¶¯ÏîÄ¿ÔñÓÅ×ÊÖú¡±Ò»Ïî
·¢±íÎÄÕ£º
1. Liu H,Tabuchi T, Takemura A, Motohashi G, etal: The granulocyte/lymphocyte ratio as an independent predictor of tumourgrowth, metastasis and progrssion: Its clinical applications. Molecular MedcineReports. 2008 1: 699-7042. Liu H,Ubukata H, Tabuchi T, Takemura A, etal: It ispossible that tumour-infiltrating granulocytes promote tumour progression.Oncol Rep. 2009 Jul22(1):29-333. Liu H, Ubukata H, Tabuchi T,Nakachi T, Nagata H, et al: Thedistribution and intracellular location of Fas and Fas Ligand following gastriccarcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit localimmune response. Mol Cell Biochem. (2009) 331:181¨C1864. Liang P, Hong JW, Ubukata H, LiuHR, et al. Increaseddensity and diameter of lymphatic microvessels correlate with lymph nodemetastasis in early stage invasive colorectal carcinoma. VirchowsArch. 2006 May448(5):570-5.5. Liu H, Liu G, Bao Q,et al. The Baseline Ratio of Neutrophils to Lymphocytes Is Associated withPatient Prognosis in rectal carcinoma. J GastrointestCancer. 2010 Feb 41(2) 116-120.6. Wang SY, Zhang Z, Fang FQ, Gao X, Sun Wand Liu HR.The neutrophil/lymphocyte ratio is an independent prognosticindicator in patients with bone metastasis. Oncolgy Letters 2: 735-740, 2011£¨Í¨Ñ¶×÷Õߣ©7. LiuHR, ZhangZ, Tabuchi T, Wang SYand WangJN.The role of pro-inflammatorycytokines and immune cells in colorectal carcinoma progression. ONCOLOGYLETTERS 5: 1177-1182, 20138. Liu HR, Song MZ, FangFQ, Gao X, Zhang Z, WangSY Prediction ofchemotherapeutic efficacyusing the ratio ofneutrophils tolymphocytesin patients with unresectable or recurrentgastric cancer. ONCOLOGY LETTERS 10: 2244-2248, 20159. Áõ»ÀÈ»£¬ÕÅÕñ£¬ÍõÊÙÓî¡£È˹¤»¢¹Ç·ÛÖÎÁÆθ´ó²¿ÇгýÊõºó¹ÇÖÊÊèËÉÖ¢µÄÁÆЧ¹Û²ìÖйú×éÖ¯¹¤³ÌÑо¿ 12:152-153£»201210. Áõ»ÀÈ»µÈ¡£³¦ÏµÄ¤Ï¶¯ÂöCT¶¯ÂöÔìÓ°·ÖÐÍÓëÁܰͽáתÒÆÏà¹ØÐÔÑо¿ÖйúʵÓÃÍâ¿ÆÔÓÖ¾35£¨7£©£º756-759£»201511. Áõ»ÀÈ»£¬ÍõÕýÁֵȡ£Ê¢ÉúƽÏûƬÖÎÁÆÈéÏÙÔöÉúÖ¢µÄÁÆЧ¹Û²ìÁÙ´²ºÏÀíÓÃÒ©ÔÓÖ¾ 8£º21-22£¬ 201512. ³ö°æÎÖ÷±àÁõ»ÀÈ»£¬¡¶ÐäÕäΣÖØÖ¢ÆÀ·ÖÊֲᡷ£¬ÈËÃñ¾üÒ½³ö°æÉçISSN**68